AXL and neoplasm: Rather than functioning as an oncogenic driver, AXL and its ligand growth arrest specific 6 (GAS6) protein are implicated in important components of the metastatic cascade, including promotion of tumour cell proliferation, survival, migration, invasion, angiogenesis, immune evasion and epithelial-to-mesenchymal transition (EMT) [14, 15].